Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intra-Aortic Balloon Pumping | 4 | 2015 | 78 | 0.370 |
Why?
|
Nutrition Therapy | 1 | 2009 | 11 | 0.360 |
Why?
|
Micronutrients | 1 | 2009 | 15 | 0.360 |
Why?
|
Heart Transplantation | 7 | 2015 | 694 | 0.350 |
Why?
|
Heart, Artificial | 4 | 1992 | 9 | 0.350 |
Why?
|
Operating Rooms | 2 | 2018 | 125 | 0.290 |
Why?
|
Postoperative Complications | 7 | 1999 | 2172 | 0.250 |
Why?
|
Heart Atria | 2 | 2015 | 238 | 0.240 |
Why?
|
Lung Transplantation | 3 | 2000 | 174 | 0.220 |
Why?
|
Myocytes, Cardiac | 2 | 2014 | 263 | 0.210 |
Why?
|
Heart Failure | 4 | 2015 | 1161 | 0.200 |
Why?
|
Bronchial Fistula | 1 | 1998 | 10 | 0.170 |
Why?
|
Vascular Fistula | 1 | 1998 | 12 | 0.170 |
Why?
|
Aortic Coarctation | 1 | 1998 | 33 | 0.170 |
Why?
|
Aortography | 1 | 1998 | 62 | 0.170 |
Why?
|
Thoracic Surgery | 1 | 2018 | 41 | 0.170 |
Why?
|
Heart | 4 | 1999 | 528 | 0.170 |
Why?
|
Bronchi | 1 | 1999 | 227 | 0.160 |
Why?
|
Aortic Diseases | 1 | 1998 | 97 | 0.160 |
Why?
|
Heart-Assist Devices | 4 | 1996 | 716 | 0.160 |
Why?
|
Patient Handoff | 1 | 2018 | 91 | 0.150 |
Why?
|
Perioperative Care | 1 | 2018 | 157 | 0.150 |
Why?
|
Stents | 1 | 1999 | 366 | 0.150 |
Why?
|
Organizational Policy | 1 | 1997 | 55 | 0.150 |
Why?
|
Resuscitation Orders | 1 | 1997 | 60 | 0.150 |
Why?
|
Critical Care | 1 | 2018 | 359 | 0.140 |
Why?
|
Intensive Care Units | 1 | 2018 | 361 | 0.140 |
Why?
|
Subclavian Artery | 1 | 2015 | 44 | 0.140 |
Why?
|
Jehovah's Witnesses | 1 | 2015 | 18 | 0.140 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2014 | 28 | 0.130 |
Why?
|
Excitation Contraction Coupling | 1 | 2014 | 5 | 0.130 |
Why?
|
Vena Cava, Superior | 1 | 2015 | 59 | 0.130 |
Why?
|
Societies, Medical | 1 | 2018 | 571 | 0.130 |
Why?
|
Urocortins | 1 | 2014 | 1 | 0.130 |
Why?
|
NFATC Transcription Factors | 1 | 2014 | 28 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2014 | 128 | 0.120 |
Why?
|
Vascular Surgical Procedures | 1 | 2015 | 149 | 0.120 |
Why?
|
Mediastinitis | 1 | 1992 | 14 | 0.110 |
Why?
|
Pulse | 1 | 1991 | 18 | 0.110 |
Why?
|
Central Venous Pressure | 1 | 1991 | 26 | 0.110 |
Why?
|
Oximetry | 1 | 1991 | 83 | 0.100 |
Why?
|
Bacterial Infections | 1 | 1992 | 182 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2000 | 2507 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 1 | 2015 | 456 | 0.100 |
Why?
|
Male | 25 | 2015 | 40460 | 0.100 |
Why?
|
Coronary Disease | 1 | 1991 | 260 | 0.090 |
Why?
|
Middle Aged | 20 | 2015 | 24751 | 0.090 |
Why?
|
Avitaminosis | 1 | 2009 | 5 | 0.090 |
Why?
|
Nutritional Requirements | 1 | 2009 | 17 | 0.090 |
Why?
|
Nutrition Policy | 1 | 2009 | 12 | 0.090 |
Why?
|
Trace Elements | 1 | 2009 | 11 | 0.090 |
Why?
|
Parenteral Nutrition | 1 | 2009 | 56 | 0.090 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2009 | 52 | 0.090 |
Why?
|
Organ Preservation | 1 | 1989 | 78 | 0.090 |
Why?
|
Intestinal Absorption | 1 | 2009 | 122 | 0.090 |
Why?
|
Magnesium | 1 | 1989 | 172 | 0.090 |
Why?
|
Enteral Nutrition | 1 | 2009 | 103 | 0.090 |
Why?
|
Vitamins | 1 | 2009 | 78 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2009 | 126 | 0.080 |
Why?
|
Adult | 17 | 2015 | 25287 | 0.080 |
Why?
|
Potassium | 1 | 2009 | 279 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 805 | 0.080 |
Why?
|
Humans | 26 | 2018 | 84493 | 0.070 |
Why?
|
Oxygen | 1 | 1991 | 726 | 0.070 |
Why?
|
Myocardium | 1 | 2009 | 523 | 0.070 |
Why?
|
Anastomosis, Surgical | 2 | 2015 | 263 | 0.070 |
Why?
|
Reoperation | 4 | 1998 | 585 | 0.070 |
Why?
|
Aged | 13 | 2015 | 18159 | 0.070 |
Why?
|
Female | 19 | 2015 | 43911 | 0.060 |
Why?
|
Vascular Resistance | 2 | 1996 | 98 | 0.060 |
Why?
|
Insulin | 1 | 2009 | 1153 | 0.060 |
Why?
|
Inflammation | 1 | 2009 | 882 | 0.060 |
Why?
|
Lung Neoplasms | 4 | 2000 | 2235 | 0.060 |
Why?
|
Rabbits | 2 | 2014 | 635 | 0.060 |
Why?
|
Hemodynamics | 3 | 1996 | 701 | 0.050 |
Why?
|
Preoperative Care | 2 | 2015 | 389 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 1995 | 1063 | 0.050 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2000 | 20 | 0.050 |
Why?
|
Ganglia, Autonomic | 1 | 1999 | 5 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 1999 | 119 | 0.040 |
Why?
|
Histamine | 1 | 1999 | 124 | 0.040 |
Why?
|
Catecholamines | 1 | 1999 | 88 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 1999 | 206 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2015 | 8152 | 0.040 |
Why?
|
Catheterization | 1 | 1999 | 228 | 0.040 |
Why?
|
Patient Transfer | 1 | 2018 | 91 | 0.040 |
Why?
|
Advance Directive Adherence | 1 | 1997 | 6 | 0.040 |
Why?
|
Ganglia | 1 | 1996 | 14 | 0.040 |
Why?
|
Survival Rate | 4 | 1995 | 1852 | 0.040 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 169 | 0.040 |
Why?
|
Thoracotomy | 2 | 1995 | 58 | 0.040 |
Why?
|
Personal Autonomy | 1 | 1997 | 111 | 0.040 |
Why?
|
Withholding Treatment | 1 | 1997 | 111 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 1996 | 56 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2015 | 47 | 0.030 |
Why?
|
Time Factors | 4 | 1992 | 5181 | 0.030 |
Why?
|
Adolescent | 4 | 1999 | 8849 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 2015 | 85 | 0.030 |
Why?
|
Thoracoscopy | 1 | 1994 | 22 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2014 | 2208 | 0.030 |
Why?
|
Hemoglobins | 1 | 2015 | 175 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2015 | 153 | 0.030 |
Why?
|
Mediastinal Diseases | 1 | 1994 | 21 | 0.030 |
Why?
|
Remission Induction | 2 | 1995 | 709 | 0.030 |
Why?
|
Parathyroid Glands | 1 | 1994 | 72 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 1997 | 185 | 0.030 |
Why?
|
Choristoma | 1 | 1994 | 68 | 0.030 |
Why?
|
Ethics, Medical | 1 | 1997 | 304 | 0.030 |
Why?
|
Informed Consent | 1 | 1997 | 262 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 88 | 0.030 |
Why?
|
Endocarditis, Bacterial | 1 | 1993 | 33 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 1995 | 129 | 0.030 |
Why?
|
Prosthesis-Related Infections | 1 | 1993 | 58 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 1993 | 92 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 254 | 0.030 |
Why?
|
Cefazolin | 1 | 1992 | 6 | 0.030 |
Why?
|
Adenoma | 1 | 1994 | 231 | 0.030 |
Why?
|
Animals | 4 | 2014 | 26197 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 313 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2014 | 276 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1998 | 1200 | 0.030 |
Why?
|
Vancomycin | 1 | 1992 | 70 | 0.030 |
Why?
|
Catheterization, Swan-Ganz | 1 | 1991 | 25 | 0.030 |
Why?
|
Counterpulsation | 1 | 1991 | 21 | 0.030 |
Why?
|
Aortic Valve | 1 | 1993 | 216 | 0.030 |
Why?
|
Mitral Valve | 1 | 1993 | 247 | 0.030 |
Why?
|
Femoral Artery | 1 | 1991 | 81 | 0.030 |
Why?
|
Heart Neoplasms | 1 | 1991 | 61 | 0.030 |
Why?
|
Catheterization, Peripheral | 1 | 1991 | 57 | 0.030 |
Why?
|
Monitoring, Intraoperative | 1 | 1991 | 108 | 0.020 |
Why?
|
Cause of Death | 1 | 1992 | 273 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 1991 | 190 | 0.020 |
Why?
|
Hemolysis | 1 | 1990 | 61 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1991 | 135 | 0.020 |
Why?
|
Calcium | 1 | 2014 | 1132 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 1995 | 2401 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 1991 | 294 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2009 | 32 | 0.020 |
Why?
|
Heart Rate | 1 | 1991 | 486 | 0.020 |
Why?
|
Length of Stay | 1 | 1992 | 683 | 0.020 |
Why?
|
Hemorrhage | 1 | 1990 | 249 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2014 | 2788 | 0.020 |
Why?
|
Lung | 1 | 1994 | 1135 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 308 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 491 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 1990 | 237 | 0.020 |
Why?
|
Swine | 1 | 2009 | 545 | 0.020 |
Why?
|
Incidence | 1 | 1992 | 1559 | 0.020 |
Why?
|
United States | 2 | 1997 | 6474 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1992 | 967 | 0.020 |
Why?
|
Glucose | 1 | 2009 | 628 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 1995 | 1651 | 0.020 |
Why?
|
Biopsy | 1 | 2009 | 1144 | 0.020 |
Why?
|
Etoposide | 2 | 1995 | 194 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 3198 | 0.010 |
Why?
|
Intestinal Perforation | 1 | 1983 | 32 | 0.010 |
Why?
|
Abdominal Injuries | 1 | 1983 | 37 | 0.010 |
Why?
|
Jejunum | 1 | 1983 | 76 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 7829 | 0.010 |
Why?
|
Wounds, Nonpenetrating | 1 | 1983 | 87 | 0.010 |
Why?
|
Feasibility Studies | 2 | 1995 | 742 | 0.010 |
Why?
|
Cisplatin | 2 | 1995 | 603 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2000 | 1262 | 0.010 |
Why?
|
Dopa Decarboxylase | 1 | 1999 | 2 | 0.010 |
Why?
|
Phenylethanolamine N-Methyltransferase | 1 | 1999 | 3 | 0.010 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 1999 | 6 | 0.010 |
Why?
|
Histidine Decarboxylase | 1 | 1999 | 5 | 0.010 |
Why?
|
Tryptophan Hydroxylase | 1 | 1999 | 10 | 0.010 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1999 | 44 | 0.010 |
Why?
|
Cross Reactions | 1 | 1999 | 106 | 0.010 |
Why?
|
Neoplasm Staging | 2 | 1995 | 1929 | 0.010 |
Why?
|
Acetylcholine | 1 | 1999 | 176 | 0.010 |
Why?
|
Norepinephrine | 1 | 1999 | 164 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2000 | 321 | 0.010 |
Why?
|
Serotonin | 1 | 1999 | 217 | 0.010 |
Why?
|
Dopamine | 1 | 1999 | 274 | 0.010 |
Why?
|
Indoles | 1 | 1999 | 316 | 0.010 |
Why?
|
Parasympathetic Nervous System | 1 | 1996 | 32 | 0.010 |
Why?
|
Vagus Nerve | 1 | 1996 | 45 | 0.010 |
Why?
|
Heart Conduction System | 1 | 1996 | 106 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 1 | 1996 | 143 | 0.010 |
Why?
|
Methods | 1 | 1995 | 152 | 0.010 |
Why?
|
Prospective Studies | 2 | 1994 | 4091 | 0.010 |
Why?
|
Ventricular Fibrillation | 1 | 1995 | 65 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 1996 | 6457 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1994 | 217 | 0.010 |
Why?
|
Parathyroidectomy | 1 | 1994 | 77 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1996 | 226 | 0.010 |
Why?
|
Tachycardia, Ventricular | 1 | 1995 | 115 | 0.010 |
Why?
|
Regression Analysis | 1 | 1995 | 599 | 0.010 |
Why?
|
Electrocardiography | 1 | 1996 | 473 | 0.010 |
Why?
|
Stroke Volume | 1 | 1996 | 434 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1993 | 57 | 0.010 |
Why?
|
Heart Diseases | 1 | 1996 | 287 | 0.010 |
Why?
|
Ohio | 1 | 1993 | 36 | 0.010 |
Why?
|
Washington | 1 | 1993 | 47 | 0.010 |
Why?
|
New York City | 1 | 1993 | 59 | 0.010 |
Why?
|
Decision Trees | 1 | 1993 | 63 | 0.010 |
Why?
|
Heart Valve Diseases | 1 | 1993 | 102 | 0.010 |
Why?
|
California | 1 | 1993 | 135 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 1366 | 0.010 |
Why?
|
Aortic Valve Insufficiency | 1 | 1993 | 129 | 0.010 |
Why?
|
Vincristine | 1 | 1991 | 109 | 0.010 |
Why?
|
Mitral Valve Insufficiency | 1 | 1993 | 185 | 0.010 |
Why?
|
Illinois | 1 | 1993 | 459 | 0.010 |
Why?
|
Prednisone | 1 | 1991 | 254 | 0.010 |
Why?
|
Doxorubicin | 1 | 1991 | 285 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1991 | 297 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1993 | 251 | 0.010 |
Why?
|
Radiotherapy | 1 | 1993 | 328 | 0.010 |
Why?
|
Recurrence | 1 | 1993 | 1128 | 0.010 |
Why?
|
Neurons | 1 | 1999 | 1508 | 0.010 |
Why?
|
Heparin | 1 | 1990 | 174 | 0.010 |
Why?
|
Waiting Lists | 1 | 1990 | 172 | 0.010 |
Why?
|
Graft Rejection | 1 | 1994 | 1058 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 1995 | 3598 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 1990 | 303 | 0.000 |
Why?
|
Wound Infection | 1 | 1983 | 17 | 0.000 |
Why?
|
Peritonitis | 1 | 1983 | 28 | 0.000 |
Why?
|
Therapeutic Irrigation | 1 | 1983 | 60 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1991 | 3351 | 0.000 |
Why?
|
Child | 1 | 1983 | 6776 | 0.000 |
Why?
|